✦ LIBER ✦

Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Scribed by Gernot Hudelist; Wolfgang J. Köstler; Daphne Gschwantler-Kaulich; Klaus Czerwenka; Ernst Kubista; Ruth Müller; Samir Helmy; Mahmood Manavi; Christoph C. Zielinski; Christian F. Singer

Book ID: 116428742
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 178 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.08.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2/neu and EGFR tyrosine kinase activ

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man

Serum HER-2/neu and relative resistance

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

✍ Suhail M. Ali; Walter P. Carney; Francisco J. Esteva; Monica Fornier; Lyndsay Ha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Rationale for the use of trastuzumab in

Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer

✍ Kadri Altundag; Ozden Altundag; Mustafa Ata Atik; Paolo Morandi; Mehmet Gunduz 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Trastuzumab and gemcitabine as salvage t

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

✍ Rupert Bartsch; Catharina Wenzel; Simon P. Gampenrieder; Ursula Pluschnig; Gabri 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 322 KB

The level of HER2/neu gene amplification

The level of HER2/neu gene amplification as predictive factor in patients with metastatic breast cancer treated with a trastuzumab-based therapy

✍ G. Gullo; D. Bettio; V. Torri; G. Masci; P. Salvini; A. Santoro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB